KRAS and pancreatic intraductal papillary-mucinous neoplasm: GNAS is often analyzed along KRAS (11,15–17,22,23) or other MAPK pathway genes (BRAF, HRAS, NRAS) (18,33) to improve the detection of IPMN and MCN.